Market Research Logo

DelveInsight

DelveInsight is a leading Business Consulting and Market Research Firm. They combine industry expertise with probing market insights in innovative ways to deliver critical information to leading decision makers. DelveInsight helps their clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledgeable partner for business strategy and market research across the drug value chain.

DelveInsight provides the intelligent information to Business and Healthcare professionals through the analytical and strategic Reports. Currently they have 3000+ Marketed and Pipeline Reports in the Market. These Reports are based on Indication, Mechanism of Actions, Drugs, Global API Manufacturers and Specialized Reports on Onco-Immunology, Orphan Diseases, Biologics & Biosimilars, Gene Therapy, Stem Cells Therapy and other upcoming areas. This platform is used by many companies to transform and redefine their businesses.

DelveInsight deals in Consulting Projects & Competitive Intelligence. In addition to this, they also provides custom research services in coherence with interest area of the clients.


...Show More ...Show Less

3565 Reports from DelveInsight

   
  • 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor -Pipeline Insights, 2017

    ...provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor by development stage, therapy type, route ... Read More

  • 20s Proteasome Inhibitor -Pipeline Insights, 2017

    ...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of 20s Proteasome Inhibitor by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More

  • 4-1BB receptor Agonist -Pipeline Insights, 2017

    ...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of 4-1BB receptor Agonist by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More

  • 50S Ribosomal Subunit (50S RNA) Inhibitor -Pipeline Insights, 2017

    ...complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of 50S Ribosomal Subunit (50S RNA) Inhibitor by development stage, therapy type, route of administration and ... Read More

  • 5-HT1 Agonist -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of 5-HT1 Agonist by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • 5-HT1 Antagonist -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of 5-HT1 Antagonist by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • Amyloid Protein Blockers -Pipeline Insights, 2017

    ...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Amyloid Protein Blockers by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More

  • Anti GM-CSF Antibody -Pipeline Insights, 2017

    ...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti GM-CSF Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More

  • Anti-CD19 Antibody -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD19 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2017

    ...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD274 (PD-L1) Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More

  • Anti-CD3 Antibody -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD3 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • Anti-CD33 Antibody -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD33 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • Anti-CD38 Antibody -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD38 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • Anti-CD40 Antibody -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD40 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • Anti-CD52 Antibody -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD52 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • Anti-CD80 Antibody -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD80 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • Anti-Mucin 1 (MUC1) Antibody -Pipeline Insights, 2017

    ...pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-Mucin 1 (MUC1) Antibody by development stage, therapy type, route of administration and molecule type is also covered in ... Read More

  • Arginine Depletors -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Arginine Depletors by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • Benzodiazepine Receptor Agonist -Pipeline Insights, 2017

    ...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Benzodiazepine Receptor Agonist by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More

  • BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors -Pipeline Insights, 2017

    ...provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors by development stage, therapy type, route ... Read More

  • Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) -Pipeline Insights, 2017

    ...complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) by development stage, therapy type, route of administration and ... Read More

  • Estrogen Receptor Beta Partial Agonist -Pipeline Insights, 2017

    ...of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Estrogen Receptor Beta Partial Agonist by development stage, therapy type, route of administration and molecule type is ... Read More

  • Factor IX -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Factor IX by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

  • Fc-Gamma Receptor Antagonist -Pipeline Insights, 2017

    ...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Fc-Gamma Receptor Antagonist by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More

  • Glucokinase Activators -Pipeline Insights, 2017

    ...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Glucokinase Activators by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More

< prev 1 3 4 5 6 7 8 9 10

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook